Investigation of the Atherogenic Effects of Uric Acid-modified in Endothelial Dysfunction and the the Preventional Mechanism by Anthocyanidines

• Status: Unknown status
• Trial end date: 2017-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to confirm the protective effect and mechanism of anthocyanins on hyperuricemia patients with Cardiovascular disease.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Guangzhou General Hospital of Guangzhou Military Command
• Collaborator: Sun Yat-sen University
• Treatments: Allopurinol; Proanthocyanidin

Criteria

Inclusion Criteria:

• Serum uric acid >420μmol/L (7mg/dL) in male, >360μmol/L (6mg/dL) in female identified as hyperuricemia patients.

Exclusion Criteria:

• Age more than 60 years and less than 30 years old;

• acute infection, tumor, recent surgery, need for hemodialysis and autoimmune diseases.